- Home
- IVDA vs PALI Comparison
IVDA vs PALI Comparison
Compare IVDA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- PALI
- Stock Information
- Founded
- IVDA 2003
- PALI 1996
- Country
- IVDA United States
- PALI United States
- Employees
- IVDA N/A
- PALI N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVDA Technology
- PALI Health Care
- Exchange
- IVDA Nasdaq
- PALI Nasdaq
- Market Cap
- IVDA 3.7M
- PALI 3.5M
- IPO Year
- IVDA N/A
- PALI N/A
- Fundamental
- Price
- IVDA $1.40
- PALI $2.52
- Analyst Decision
- IVDA
- PALI Strong Buy
- Analyst Count
- IVDA 0
- PALI 1
- Target Price
- IVDA N/A
- PALI $8.00
- AVG Volume (30 Days)
- IVDA 213.5K
- PALI 198.8K
- Earning Date
- IVDA 11-25-2024
- PALI 11-12-2024
- Dividend Yield
- IVDA N/A
- PALI N/A
- EPS Growth
- IVDA N/A
- PALI N/A
- EPS
- IVDA N/A
- PALI N/A
- Revenue
- IVDA $5,305,154.00
- PALI N/A
- Revenue This Year
- IVDA $23.76
- PALI N/A
- Revenue Next Year
- IVDA $229.89
- PALI N/A
- P/E Ratio
- IVDA N/A
- PALI N/A
- Revenue Growth
- IVDA N/A
- PALI N/A
- 52 Week Low
- IVDA $1.27
- PALI $2.18
- 52 Week High
- IVDA $10.16
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- IVDA 43.18
- PALI 38.02
- Support Level
- IVDA $1.27
- PALI $2.20
- Resistance Level
- IVDA $1.56
- PALI $2.71
- Average True Range (ATR)
- IVDA 0.22
- PALI 0.31
- MACD
- IVDA 0.01
- PALI -0.03
- Stochastic Oscillator
- IVDA 20.00
- PALI 25.76
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.